List of Tables
Table 1. Hypertension Drug Market Trends
Table 2. Hypertension Drug Market Drivers & Opportunity
Table 3. Hypertension Drug Market Challenges
Table 4. Hypertension Drug Market Restraints
Table 5. Global Hypertension Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Hypertension Drug Revenue Market Share by Company (2019-2024)
Table 7. Global Hypertension Drug Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Hypertension Drug Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Hypertension Drug Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Hypertension Drug Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Hypertension Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Hypertension Drug
Table 13. Global Hypertension Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension Drug as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Hypertension Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Hypertension Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Hypertension Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Hypertension Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Hypertension Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Hypertension Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Hypertension Drug Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Hypertension Drug Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Hypertension Drug Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Hypertension Drug Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Hypertension Drug Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Hypertension Drug Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Hypertension Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Hypertension Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Hypertension Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Hypertension Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Hypertension Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Hypertension Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Hypertension Drug Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Hypertension Drug Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Hypertension Drug Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Hypertension Drug Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Hypertension Drug Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Hypertension Drug Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Hypertension Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Hypertension Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Hypertension Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Hypertension Drug Sales Value by Region (2019-2024) & (%)
Table 44. Global Hypertension Drug Sales Value by Region (2025-2030) & (%)
Table 45. Global Hypertension Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Hypertension Drug Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Hypertension Drug Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Hypertension Drug Sales Volume by Region (2019-2024) & (%)
Table 49. Global Hypertension Drug Sales Volume by Region (2025-2030) & (%)
Table 50. Global Hypertension Drug Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Hypertension Drug Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Hypertension Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Hypertension Drug Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Hypertension Drug Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Hypertension Drug Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Hypertension Drug Sales Volume, (2025-2030) & (K Units)
Table 57. Actelion Ltd. Company Information
Table 58. Actelion Ltd. Introduction and Business Overview
Table 59. Actelion Ltd. Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Actelion Ltd. Hypertension Drug Product Offerings
Table 61. Actelion Ltd. Recent Development
Table 62. Alvogen Company Information
Table 63. Alvogen Introduction and Business Overview
Table 64. Alvogen Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Alvogen Hypertension Drug Product Offerings
Table 66. Alvogen Recent Development
Table 67. AstraZeneca Plc Company Information
Table 68. AstraZeneca Plc Introduction and Business Overview
Table 69. AstraZeneca Plc Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. AstraZeneca Plc Hypertension Drug Product Offerings
Table 71. AstraZeneca Plc Recent Development
Table 72. Bayer AG Company Information
Table 73. Bayer AG Introduction and Business Overview
Table 74. Bayer AG Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Bayer AG Hypertension Drug Product Offerings
Table 76. Bayer AG Recent Development
Table 77. Bellerophon Therapeutics, Inc Company Information
Table 78. Bellerophon Therapeutics, Inc Introduction and Business Overview
Table 79. Bellerophon Therapeutics, Inc Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Bellerophon Therapeutics, Inc Hypertension Drug Product Offerings
Table 81. Bellerophon Therapeutics, Inc Recent Development
Table 82. Boehringer Ingelheim Company Information
Table 83. Boehringer Ingelheim Introduction and Business Overview
Table 84. Boehringer Ingelheim Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Boehringer Ingelheim Hypertension Drug Product Offerings
Table 86. Boehringer Ingelheim Recent Development
Table 87. Boryung Pharmaceutical Co.,Ltd Company Information
Table 88. Boryung Pharmaceutical Co.,Ltd Introduction and Business Overview
Table 89. Boryung Pharmaceutical Co.,Ltd Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Boryung Pharmaceutical Co.,Ltd Hypertension Drug Product Offerings
Table 91. Boryung Pharmaceutical Co.,Ltd Recent Development
Table 92. Bristol-Myers Squibb and Company, Company Information
Table 93. Bristol-Myers Squibb and Company, Introduction and Business Overview
Table 94. Bristol-Myers Squibb and Company, Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Bristol-Myers Squibb and Company, Hypertension Drug Product Offerings
Table 96. Bristol-Myers Squibb and Company, Recent Development
Table 97. Daiichi Sankyo Company Company Information
Table 98. Daiichi Sankyo Company Introduction and Business Overview
Table 99. Daiichi Sankyo Company Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Daiichi Sankyo Company Hypertension Drug Product Offerings
Table 101. Daiichi Sankyo Company Recent Development
Table 102. Eli Lilly and Company Company Information
Table 103. Eli Lilly and Company Introduction and Business Overview
Table 104. Eli Lilly and Company Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Eli Lilly and Company Hypertension Drug Product Offerings
Table 106. Eli Lilly and Company Recent Development
Table 107. F. Hoffmann-La Roche Ltd. Company Information
Table 108. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 109. F. Hoffmann-La Roche Ltd. Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. F. Hoffmann-La Roche Ltd. Hypertension Drug Product Offerings
Table 111. F. Hoffmann-La Roche Ltd. Recent Development
Table 112. Gilead Sciences, Inc Company Information
Table 113. Gilead Sciences, Inc Introduction and Business Overview
Table 114. Gilead Sciences, Inc Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Gilead Sciences, Inc Hypertension Drug Product Offerings
Table 116. Gilead Sciences, Inc Recent Development
Table 117. HanAll Biopharma Co., Ltd Company Information
Table 118. HanAll Biopharma Co., Ltd Introduction and Business Overview
Table 119. HanAll Biopharma Co., Ltd Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. HanAll Biopharma Co., Ltd Hypertension Drug Product Offerings
Table 121. HanAll Biopharma Co., Ltd Recent Development
Table 122. Hanmi Pharmaceutical Co., Ltd Company Information
Table 123. Hanmi Pharmaceutical Co., Ltd Introduction and Business Overview
Table 124. Hanmi Pharmaceutical Co., Ltd Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Hanmi Pharmaceutical Co., Ltd Hypertension Drug Product Offerings
Table 126. Hanmi Pharmaceutical Co., Ltd Recent Development
Table 127. Johnson & Johnson Ltd Company Information
Table 128. Johnson & Johnson Ltd Introduction and Business Overview
Table 129. Johnson & Johnson Ltd Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Johnson & Johnson Ltd Hypertension Drug Product Offerings
Table 131. Johnson & Johnson Ltd Recent Development
Table 132. JW Pharmaceutical Corporation (Choongwae Pharma) Company Information
Table 133. JW Pharmaceutical Corporation (Choongwae Pharma) Introduction and Business Overview
Table 134. JW Pharmaceutical Corporation (Choongwae Pharma) Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. JW Pharmaceutical Corporation (Choongwae Pharma) Hypertension Drug Product Offerings
Table 136. JW Pharmaceutical Corporation (Choongwae Pharma) Recent Development
Table 137. Kyowa Kirin Co., Ltd Company Information
Table 138. Kyowa Kirin Co., Ltd Introduction and Business Overview
Table 139. Kyowa Kirin Co., Ltd Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Kyowa Kirin Co., Ltd Hypertension Drug Product Offerings
Table 141. Kyowa Kirin Co., Ltd Recent Development
Table 142. Lupin Limited Company Information
Table 143. Lupin Limited Introduction and Business Overview
Table 144. Lupin Limited Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Lupin Limited Hypertension Drug Product Offerings
Table 146. Lupin Limited Recent Development
Table 147. Merck & Co. Company Information
Table 148. Merck & Co. Introduction and Business Overview
Table 149. Merck & Co. Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Merck & Co. Hypertension Drug Product Offerings
Table 151. Merck & Co. Recent Development
Table 152. Noden Pharma DAC Company Information
Table 153. Noden Pharma DAC Introduction and Business Overview
Table 154. Noden Pharma DAC Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. Noden Pharma DAC Hypertension Drug Product Offerings
Table 156. Noden Pharma DAC Recent Development
Table 157. Novartis AG Company Information
Table 158. Novartis AG Introduction and Business Overview
Table 159. Novartis AG Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 160. Novartis AG Hypertension Drug Product Offerings
Table 161. Novartis AG Recent Development
Table 162. Pfizer Inc Company Information
Table 163. Pfizer Inc Introduction and Business Overview
Table 164. Pfizer Inc Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 165. Pfizer Inc Hypertension Drug Product Offerings
Table 166. Pfizer Inc Recent Development
Table 167. Ranbaxy Laboratories Limited Company Information
Table 168. Ranbaxy Laboratories Limited Introduction and Business Overview
Table 169. Ranbaxy Laboratories Limited Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 170. Ranbaxy Laboratories Limited Hypertension Drug Product Offerings
Table 171. Ranbaxy Laboratories Limited Recent Development
Table 172. Sanofi S.A Company Information
Table 173. Sanofi S.A Introduction and Business Overview
Table 174. Sanofi S.A Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 175. Sanofi S.A Hypertension Drug Product Offerings
Table 176. Sanofi S.A Recent Development
Table 177. Lung Biotechnology PBC Introduction and Business Overview
Table 178. Lung Biotechnology PBC Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Lung Biotechnology PBC Hypertension Drug Product Offerings
Table 180. Lung Biotechnology PBC Recent Development
Table 181. Lung Biotechnology PBC Company Information
Table 182. Nippon Shinyaku Co. Ltd Company Information
Table 183. Nippon Shinyaku Co. Ltd Introduction and Business Overview
Table 184. Nippon Shinyaku Co. Ltd Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 185. Nippon Shinyaku Co. Ltd Hypertension Drug Product Offerings
Table 186. Nippon Shinyaku Co. Ltd Recent Development
Table 187. Novartis AG Company Information
Table 188. Novartis AG Introduction and Business Overview
Table 189. Novartis AG Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 190. Novartis AG Hypertension Drug Product Offerings
Table 191. Novartis AG Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Hypertension Drug Downstream Customers
Table 195. Hypertension Drug Distributors List
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Hypertension Drug Product Picture
Figure 2. Global Hypertension Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hypertension Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Hypertension Drug Sales Volume (2019-2030) & (K Units)
Figure 5. Global Hypertension Drug Sales Price (2019-2030) & (USD/Unit)
Figure 6. Hypertension Drug Report Years Considered
Figure 7. Global Hypertension Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Hypertension Drug Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hypertension Drug Revenue in 2023
Figure 10. Hypertension Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Calcium Channel Blockers Picture
Figure 12. Diuretics Picture
Figure 13. Beta Blockers Vasodilators Picture
Figure 14. Angiotensin Converting Enzyme Inhibitors Picture
Figure 15. Alpha Blockers Picture
Figure 16. Angiotensin Receptor Blockers Picture
Figure 17. Renin Inhibitors Picture
Figure 18. Global Hypertension Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Hypertension Drug Sales Value Market Share by Type, 2023 & 2030
Figure 20. Global Hypertension Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 21. Global Hypertension Drug Sales Volume Market Share by Type, 2023 & 2030
Figure 22. Global Hypertension Drug Price by Type (2019-2030) & (USD/Unit)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Private Clinic
Figure 25. Product Picture of Others
Figure 26. Global Hypertension Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Hypertension Drug Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Hypertension Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 29. Global Hypertension Drug Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Hypertension Drug Price by Application (2019-2030) & (USD/Unit)
Figure 31. North America Hypertension Drug Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Hypertension Drug Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Hypertension Drug Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Hypertension Drug Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Hypertension Drug Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Hypertension Drug Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Hypertension Drug Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Hypertension Drug Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Hypertension Drug Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Hypertension Drug Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Hypertension Drug Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Hypertension Drug Sales Volume (%), (2019-2030)
Figure 43. United States Hypertension Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Hypertension Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Hypertension Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Hypertension Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Hypertension Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Hypertension Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. China Hypertension Drug Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Hypertension Drug Sales Value by Type (%), 2023 VS 2030
Figure 51. China Hypertension Drug Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Hypertension Drug Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Hypertension Drug Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Hypertension Drug Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Hypertension Drug Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Hypertension Drug Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Hypertension Drug Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Hypertension Drug Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Hypertension Drug Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Hypertension Drug Sales Value by Application (%), 2023 VS 2030
Figure 61. India Hypertension Drug Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Hypertension Drug Sales Value by Type (%), 2023 VS 2030
Figure 63. India Hypertension Drug Sales Value by Application (%), 2023 VS 2030
Figure 64. Hypertension Drug Industrial Chain
Figure 65. Hypertension Drug Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
